2022
DOI: 10.7759/cureus.32603
|View full text |Cite
|
Sign up to set email alerts
|

Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report

Abstract: Hydralazine is a vasodilator used in the treatment of resistant hypertension. It is a safe and widely used antihypertensive medicine. Its common adverse effects include headache, rebound tachycardia, fluid retention, and angina. It is a rare cause of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) with pulmonary and renal involvement. We report a case of a 74-year-old woman, with over eight years of use of hydralazine, who presented to the hospital with shortness of breath and cough. Bl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Although the precise mechanism is unknown, it is believed to involve the drug triggering the formation of ANCA, which damages small blood vessels in different organs. Additionally, there is an increase in drug-induced AAV in females, those older than 60, and people who suffer from diabetes, heart failure, or pre-existing renal disease [ 1 , 5 ]. Even though the most likely diagnosis in this case was hydralazine-induced AAV with CrGN, it is crucial to take additional differential diagnoses into account to guarantee an accurate diagnosis and course of therapy.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the precise mechanism is unknown, it is believed to involve the drug triggering the formation of ANCA, which damages small blood vessels in different organs. Additionally, there is an increase in drug-induced AAV in females, those older than 60, and people who suffer from diabetes, heart failure, or pre-existing renal disease [ 1 , 5 ]. Even though the most likely diagnosis in this case was hydralazine-induced AAV with CrGN, it is crucial to take additional differential diagnoses into account to guarantee an accurate diagnosis and course of therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Hydralazine, a vasodilator used in the treatment of hypertension, is a rare cause of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary and renal involvement [ 1 ]. AAV is a pauci-immune inflammatory condition characterized by small vessel necrotizing vasculitis [ 2 ].…”
Section: Introductionmentioning
confidence: 99%